Skip to content

13F-HR filed by Lamond Capital Partners LLC

Lamond Capital Partners LLC filed this 13F-HR for the quarter ended 2015-03-31, filed 2015-05-12, with 12 holding rows worth $91,519,000.

Accession
0001542550-15-000003
Filed
2015-05-12
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2015

A holdings report, 12 entries on the cover page, a total value of $91,519,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $91,518,000 with VALUE read as thousands by filing date, 13F file number 028-15156. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
OCULAR THERAPEUTIX INC67576A100COM420,243$17,644,000thousands by filing date
GW PHARMACEUTICALS PLC36197T103ADS171,496$15,628,000thousands by filing date
Gilead Sciences,Inc.375558103COM120,000$11,776,000thousands by filing date
INFOBLOX INC45672H104COM429,922$10,262,000thousands by filing date
NIMBLE STORAGE INC65440R101COM360,100$8,034,000thousands by filing date
Amgen Inc.031162100COM47,590$7,607,000thousands by filing date
KITE PHARMA INC49803L109COM104,250$6,013,000thousands by filing date
DEALERTRACK TECHNOLOGIES INC242309102COM151,990$5,855,000thousands by filing date
ZYNGA INC.98986T108CL A1,580,770$4,505,000thousands by filing date
VIOLIN MEMORY I92763A101Common Stock448,101$1,689,000thousands by filing date
KING DIGITAL ENTMT PLCG5258J109ORD SHS102,720$1,648,000thousands by filing date
BELLICUM PHARMACEUTICALS INC079481107COM37,000$857,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001542550-15-000003this filing2015-05-12acceptance time not in the bulk data set